Miscellaneous ocular agents:

Indications for: MACUGEN

Treatment of neovascular (wet) age-related macular degeneration.

Adult Dosage:

Give by intravitreous inj. 0.3mg once every 6 weeks into the eye to be treated.

Children Dosage:

Not recommended.

MACUGEN Contraindications:

Ocular or periocular infections.

MACUGEN Warnings/Precautions:

Monitor for infection during week following inj (endophthalmitis possible). Monitor intraocular pressure and perfusion of optic nerve. Pregnancy (Cat.B). Nursing mothers.

MACUGEN Classification:

Vascular endothelial growth factor (VEGF) inhibitor.

Adverse Reactions:

Anterior chamber inflammation, blurred vision, cataract, conjunctival hemorrhage, corneal edema, eye discharge, eye irritation, eye pain, hypertension, increased intraocular pressure, ocular discomfort, punctate keratitis, reduced visual acuity, visual disturbances, vitreous floaters, vitreous opacities, blepharitis, conjunctivitis, photopsia, bronchitis, diarrhea, dizziness, headache, nausea, UTI, others.

How Supplied:

Pre-filled syringe—1